Market news — every asset we track

Assets

EFTR

Attovia Therapeutics Appoints John W. Smither to Board of Directors

Mr. Smither brings extensive public company board and audit committee experience in the biotechnology sectorSAN CARLOS, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Attovia Therapeutics, Inc. (“Attovia” or the “Company”), a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need, today announced the appointment of John W. Smither to its Board of Directors as an independent director and as Chair of the Audit Committee. “We

Jul 15Yahoo Finance

EFTR

This is the newest page. Registered accounts read further back.